arrow
K

Kateřina Machová Poláková

Institute of Hematology and Blood Transfusion
H指数:26
被引数:2,967

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Somatic mutations and outcomes in chronic myeloid leukemia adolescent and young adults compared to children, adults, and BCR::ABL1-positive acute lymphoblastic leukemia

体细胞突变和结局在慢性髓系白血病青少年及年轻成人中与儿童、成人及BCR::ABL1阳性急性淋巴细胞白血病的比较

LEUKEMIA
IF13.4
2025-04-280
OA
Clinical and Prognostic Significance of Additional Chromosomal Abnormalities at Diagnosis of Chronic Myeloid Leukemia

慢性髓性白血病诊断时额外染色体异常的临床及预后意义

2025-01-280
PRE
Distinct pattern of genomic breakpoints in CML and BCR::ABL1-positive ALL: analysis of 971 patients
2024-07-051
OAAI
Why are not all eligible chronic myeloid leukemia patients willing to attempt tyrosine kinase inhibitor discontinuation? A Czech nationwide analysis related to the TKI stopping trial HALF
LEUKEMIA
IF13.4
2024-03-120
OAAI
De novo accelerated phase of chronic myeloid leukemia should be recognized even in the era of tyrosine kinase inhibitors
2024-02-051
OAAI
The SNP rs460089 in the gene promoter of the drug transporter OCTN1 has prognostic value for treatment-free remission in chronic myeloid leukemia patients treated with imatinib

药物转运体OCTN1基因启动子中的SNP rs460089对伊马替尼治疗的慢性粒细胞白血病患者的无治疗缓解具有预后价值

LEUKEMIA
IF13.4
2023-12-213
OAAI
Impact of BCR::ABL1 transcript type on RT-qPCR amplification performance and molecular response to therapy
LEUKEMIA
IF13.4
2022-06-0810
OAAI
Standardization of molecular monitoring of CML: results and recommendations from the European treatment and outcome study
LEUKEMIA
IF13.4
2022-05-2517
OAAI
Somatic Mutations in Oncogenes Are in Chronic Myeloid Leukemia Acquired De Novo via Deregulated Base-Excision Repair and Alternative Non-Homologous End Joining
2021-09-208
OAAI
Persistence of Drug-Resistant Leukemic Stem Cells and Impaired NK Cell Immunity in CML Patients Depend on MIR300 Antiproliferative and PP2A-Activating Functions
2020-07-0131
OA
Analysis of chronic myeloid leukaemia during deep molecular response by genomic PCR: a traffic light stratification model with impact on treatment-free remission
LEUKEMIA
IF13.4
2020-05-2917
OAAI